Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow’s standard of care to cure cancer & infectious diseases and improve patient quality of life. Its main activities includes drug development, drug manufacturing and digital health investment.
The headquarter is located in Laisanne.